$7.29 Million Recovery for Injuries Due to Recalled Anti-Cholesterol Medication
- March 02, 2020
This litigation handled by Martin Rubenstein resulted in confidential settlements on behalf of a group of patients who used a now withdrawn anti-cholesterol medication that caused rhabdomyolysis, a debilitating kidney disorder. Due to the confidentiality terms of the settlement, the parties and precise details of the case cannot be disclosed.